Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Two Genome Kits Launched

By HospiMedica staff writers
Posted on 01 May 2006
Two new products simplify and accelerate the process of genomic DNA preparation and enable large quantities of DNA to be produced from minimal starting materials.

The illustra GenomiPhi HY DNA amplification kit and the illustra GenomiPhi V2 DNA amplification kit, provide a quick and reliable method for genomic DNA stock replenishment, and for DNA preparation upstream of polymerase chain reaction (PCR), genotyping, array comparative genomic hybridization (CGH), and cloning applications. More...
Designed by GE Healthcare (St Giles, UK), the kits use Phi 29 DNA polymerase technology, which is based on a simple isothermal method of whole genome amplification.

Both kits feature a simple process that requires only a waterbath or thermocycler, and both can be used with common automation instrumentation. The GenomiPhi HY kit is a new product for midi-scale DNA preparation, combining high DNA yield (50 µg) with fast reaction time (less than four hours), and provides high reproducibility and less hands-on time. The GenomiPhi V2 kit replaces GE Healthcare's original GenomiPhi kit for small-scale DNA preparation, providing shorter reaction times (90 minutes versus overnight) with reduced background amplification.

"The new illustra GenomiPhi kits demonstrate a reduction in reaction time relative to the earlier version of the kit and other competitive offerings. This will allow researchers to complete genomic DNA preparation and downstream application analysis within the same working day,” stated Lucy Sha, marketing director for gene and protein amplification and expression at GE Healthcare. "The illustra GenomiPhi kits will allow researchers to generate micrograms of amplified product from nanogram amounts of input DNA, which helps researchers save time and money by eliminating the need to go back to source material for DNA stock replenishment, and simplifies the process of genomic DNA preparation for disease-association studies.”



Related Links:
GE Healthcare

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.